CIK 0001719406 · Non-accelerated filer<br>Smaller reporting company
NRX Pharmaceuticals, Inc.
Sign in to watch- Ticker
- NRXP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 822844431
- Phone
- 484-254-6134
- Business address
- 1201 ORANGE STREET, SUITE 600, WILMINGTON, DE, 19801
- Former names
- Big Rock Partners Acquisition Corp.
- 8-K Event Bylaws or fiscal year change · Shareholder vote results
- 10-Q Report Quarterly Report
- 8-K Event Delisting notice
- DEF 14A Proxy Proxy Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event New debt or obligation · Other events
- 8-K Event Other events
- 8-K Event Bylaws or fiscal year change · Shareholder vote results
- 10-Q Report Quarterly Report
- DEF 14A Proxy Proxy Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- 10-K Report Annual Report
- 8-K Event New debt or obligation · Other events
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Delisting notice
- SC 13D Stake Beneficial Ownership Report
- 3 Insider Initial Statement of Ownership
- SC 13D/A Stake Beneficial Ownership Report
Page 22 of 24 · 479 filings